Table 3.
Comparison of omega - 3 and placebo in patients with rheumatoid arthritis at the beginning and end of the study
| Placebo | Omega-3 | |
|---|---|---|
| Morning Stiffness | ||
| Baseline | 116 | 128 |
| End of study | 94 | 40 |
| Number of tender joints | ||
| Baseline | 24 | 21 |
| End of study | 20 | 5 |
| Number of swollen joints | ||
| Baseline | 7 | 10 |
| End of study | 5 | 3 |
| ESR | ||
| Baseline | 35 | 39 |
| End of study | 33 | 16 |
| CRP | ||
| Baseline | 2 | 2 |
| End of study | +2 to +3 | 0 to +1 |
| RF | ||
| Baseline | 100 +% | 100 +% |
| End of study | 85 +% | 40 +% |
| Patient’s pain assessment | ||
| Baseline | 8 | 9 |
| End of study | 8 | 4 |
| Doctor’s pain assessment | ||
| Baseline | 4 | 4 |
| End of study | 5 | 2 |
| Weight | ||
| Baseline | 70 | 64.3 |
| End of study | 71 | 64.5 |
| Use of analgesics | ||
| Baseline | 24 | 25 |
| End of study | 22 | 7 |